Claesson-Welsh L, Welsh M, Ito N, Anand-Apte B, Soker S, Zetter B, O'Reilly M, Folkman J
Department of Medical Biochemistry and Microbiology, Biomedical Center, Box 575, S-751 23 Uppsala, Sweden.
Proc Natl Acad Sci U S A. 1998 May 12;95(10):5579-83. doi: 10.1073/pnas.95.10.5579.
Angiostatin, a fragment of plasminogen, has been identified and characterized as an endogenous inhibitor of neovascularization. We show that angiostatin treatment of endothelial cells in the absence of growth factors results in an increased apoptotic index whereas the proliferation index is unchanged. Angiostatin also inhibits migration and tube formation of endothelial cells. Angiostatin treatment has no effect on growth factor-induced signal transduction but leads to an RGD-independent induction of the kinase activity of focal adhesion kinase, suggesting that the biological effects of angiostatin relate to subversion of adhesion plaque formation in endothelial cells.
血管抑素是纤溶酶原的一个片段,已被鉴定并表征为一种内源性血管生成抑制剂。我们发现,在缺乏生长因子的情况下,用血管抑素处理内皮细胞会导致凋亡指数增加,而增殖指数不变。血管抑素还会抑制内皮细胞的迁移和管状结构形成。血管抑素处理对生长因子诱导的信号转导没有影响,但会导致粘着斑激酶激酶活性的RGD非依赖性诱导,这表明血管抑素的生物学效应与内皮细胞粘着斑形成的破坏有关。